-
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Study
EGAS00001007160
-
Deciphering the mutational landscape and the genome organization of LMS
Study
EGAS00001001262
-
Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis
Study
EGAS00001001723
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001001293
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit
Study
EGAS00001005053
-
Integrated molecular analysis of adult T-cell leukemia/lymphoma
Study
EGAS00001001296
-
Clonal selection and double hit events involving tumor suppressor genes underlie relapse from total therapy
Study
EGAS00001001810
-
Anal SCC cell line and parent tumour comparative whole exome sequencing
Study
EGAS00001005077
-
Genetic analysis of HLA and immune escape genes in Diffuse Large B-cell Lymphoma
Study
EGAS00001005054
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
RNA-sequencing of adult T-cell leukemia/lymphoma samples
Study
EGAS00001003575
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Mutational analysis of an oligoprogressive sarcomatoid hepatocellular carcinoma treated with an immune checkpoint inhibitor.
Study
EGAS00001005064
-
Multi-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Study
EGAS00001001871
-
Phylogenetic evolution of metastatic melanoma.
Study
EGAS00001003582
-
Genomic Landscape of Malignant Peripheral Nerve Sheath Tumor-like Melanoma
Study
EGAS00001005065
-
Whole-exome sequencing of hepatocellular carcinoma biopsies (proteogenomic study)
Study
EGAS00001005073
-
Carcinoma of the oral tongue (OTSCC) genomic landscape characterisation
Study
EGAS00001001329
-
ARAF Mutations Confer Resistance to RAF Dimer Inhibitor Belvarafenib in NRAS- and BRAF- Mutant Melanoma
Study
EGAS00001005086
-
A somatic reference standard for cancer genome sequencing with COLO829
Study
EGAS00001001385
-
Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study
Study
EGAS00001001516
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
A comprehensive assessment of somatic mutation detection in cancer using whole genome sequencing
Study
EGAS00001001539
-
Whole genome sequencing of primary and metastatic Melanoma cases in an Australian cohort.
Study
EGAS00001001552
-
PSCP_mutation_analysis_in_hESCs
Study
EGAS00001001561
-
Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer
Study
EGAS00001005108
-
Mutational landscape of renal cell carcinoma with venous tumor thrombus
Study
EGAS00001001950
-
Integrated genomic characterization of IDH1 mutant Glioma malignant progression
Study
EGAS00001001588
-
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes
Study
EGAS00001001601
-
Recapitulation of genetic predisposition to medulloblastoma in human neuroepithelial stem cells
Study
EGAS00001003620
-
A Phase II Trial of High Dose Interleukin-2 and Multi-site Stereotactic Ablative Radiotherapy for Patients with Metastatic Renal Cell Carcinoma
Study
EGAS00001003605
-
Whole-genome landscape of adult T-cell leukemia/lymphoma
Study
EGAS00001005237
-
SCAT_osteosarcoma_sequencing
Study
EGAS00001000196
-
MED12L Gene Alterations Define Aggressive BRCA2-Mutant Prostate Cancers
Study
EGAS00001001615
-
Accurate detection and classification of pediatric sarcomas based on cell-free DNA fragmentation patterns
Study
EGAS00001005127
-
Multiregional sequencing of IDH-WT glioblastoma reveals high genetic heterogeneity and a dynamic evolutionary history
Study
EGAS00001005128
-
BLUEPRINT DNA Methylation 450K data of mantle cell lymphoma
Study
EGAS00001001637
-
Spatial and Temporal Homogeneity of Driver Mutations in Diffuse Intrinsic Pointine Glioma
Study
EGAS00001001654
-
33 patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) had whole exome sequencing performed. Cells were sorted by FACSAria using CD138, CD19 and CD56 to obtain a pure abnormal plasma cell population. Generated somatic variants were compared to a previous study of 463 multiple myeloma patients.
Study
EGAS00001001658
-
Engineering large chromosomal deletions by CRISPR-Cas9
Study
EGAS00001005134
-
Paired exome analysis in urothelial carcinoma
Study
EGAS00001001686
-
Whole exome sequencing on primary retinoblastoma tissues and matching lymphocyte DNA.
Study
EGAS00001001690
-
Identifying_Novel_Fusion_Genes_in_Myeloma
Study
EGAS00001000220
-
Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study
Study
EGAS00001001709
-
Splicing patterns in SF3B1 mutated uveal melanoma generate shared immunogenic tumor-specific neo-epitopes
Study
EGAS00001005226
-
Single-cell RNA sequencing on 5063 single T cells isolated from peripheral blood, tumour and adjacent normal tissues from six hepatocellular carcinoma patients.
Study
EGAS00001002072
-
UAMS Smoldering Myeloma Myeloma Sequencing
Study
EGAS00001003629
-
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing
Study
EGAS00001001736
-
Paired exome and low-coverage genome sequencing of osteosarcoma
Study
EGAS00001005199